Tvardi Therapeutics is trading at $0.93, up +10.37% in after-hours trading; no clear company-specific announcement explaining the rise was identified.
- The latest company release found was the October 14 conference announcement; October 20 conference coverage is earlier context, not a confirmed catalyst.
- The regular-session close was $0.84, down 10.41% on October 26, while major indexes ended higher; that performance does not clearly explain the later after-hours move.
- No after-hours volume or trading-activity details were provided.